HUTCHMED (China) Limited - ADR
HCM
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.79B
Close$
$18.74
87.6% upside
Current Fair Value
87.6% upsideUndervalued by 87.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.79 Billion |
|---|---|
| Enterprise Value | $1.82 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $2.65 |
| Beta | 0.37 |
| Outstanding Shares | 174,982,307 |
Return
| Return on Equity | 37.71% |
|---|---|
| Return on Assets | 26.63% |
| Return on Invested Capital | -1.37% |
Valuation & Multiples
| P/E Ratio | 3.86 |
|---|---|
| PEG | 0.49 |
| Price to Sales | 3.33 |
| Price to Book Ratio | 1.43 |
| Enterprise Value to Revenue | 3.03 |
| Enterprise Value to EBIT | -92.51 |
| Enterprise Value to Net Income | 3 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.08 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
June 18, 2026
EPS Estimate
$-0.36
Average shareholder expectationRevenue Estimate
$80.92 M
Average shareholder expectationNext Earnings Call
Expected Date
August 3, 2026
EPS Estimate
$0.15
Average shareholder expectationRevenue Estimate
$306.40 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 2.49%▼ 0.47% |
|---|---|
| Total Invested | $63.96M▼ 7.47% |
| Investors Holding | 53▲ 5.00% |
ESG Score
No data
About Hutchison China Meditech Ltd.
CEO: Christian Hogg